DK151330C - Analogifremgangsmaade til fremstilling af aminoalkoholderivater eller farmaceutiske acceptable salte deraf - Google Patents
Analogifremgangsmaade til fremstilling af aminoalkoholderivater eller farmaceutiske acceptable salte derafInfo
- Publication number
- DK151330C DK151330C DK517076A DK517076A DK151330C DK 151330 C DK151330 C DK 151330C DK 517076 A DK517076 A DK 517076A DK 517076 A DK517076 A DK 517076A DK 151330 C DK151330 C DK 151330C
- Authority
- DK
- Denmark
- Prior art keywords
- aminoal
- analogue
- preparation
- acceptable salts
- pharmaceutical acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
- C07D337/02—Seven-membered rings
- C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7535217 | 1975-11-18 | ||
FR7535217A FR2332010A1 (fr) | 1975-11-18 | 1975-11-18 | Amino-alcool heterocyclique, son sel et son procede de preparation |
Publications (3)
Publication Number | Publication Date |
---|---|
DK517076A DK517076A (da) | 1977-05-19 |
DK151330B DK151330B (da) | 1987-11-23 |
DK151330C true DK151330C (da) | 1988-04-25 |
Family
ID=9162563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK517076A DK151330C (da) | 1975-11-18 | 1976-11-17 | Analogifremgangsmaade til fremstilling af aminoalkoholderivater eller farmaceutiske acceptable salte deraf |
Country Status (21)
Country | Link |
---|---|
JP (2) | JPS5297952A (sv) |
AT (1) | AT355566B (sv) |
AU (1) | AU510315B2 (sv) |
BE (1) | BE848496A (sv) |
CA (1) | CA1094088A (sv) |
CH (2) | CH623321A5 (sv) |
DE (1) | DE2651572C2 (sv) |
DK (1) | DK151330C (sv) |
ES (1) | ES453389A1 (sv) |
FI (1) | FI763265A (sv) |
FR (1) | FR2332010A1 (sv) |
GB (1) | GB1565080A (sv) |
GR (1) | GR62012B (sv) |
IE (1) | IE44265B1 (sv) |
IL (1) | IL50932A (sv) |
MX (1) | MX4881E (sv) |
NL (1) | NL180936C (sv) |
NZ (1) | NZ182665A (sv) |
PT (1) | PT65853B (sv) |
SE (1) | SE434744B (sv) |
ZA (1) | ZA766907B (sv) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2512817A1 (fr) * | 1981-09-17 | 1983-03-18 | Roussel Uclaf | Nouveaux derives de l'aminomethyl 1h-indole-4-methanol et leurs sels, leur procede de preparation, leur application a titre de medicaments, les compositions les renfermant et leurs intermediaires de preparation |
US4562200A (en) * | 1983-06-30 | 1985-12-31 | American Home Products Corporation | 5(Indolyl) and 5(2,3-dihydroindolyl) substituted aminoethanols and their use as anti-hypertensives |
US4521606A (en) * | 1983-06-30 | 1985-06-04 | American Home Products Corp. | 5-Indolyl substituted aminoethanols |
US4622399A (en) * | 1983-06-30 | 1986-11-11 | American Home Products Corporation | Bicyclo-heterocyclic nitrogen substituted aminoethanol derivatives |
EP0567090B1 (en) | 1992-04-24 | 2000-07-26 | Takeda Chemical Industries, Ltd. | Benzoxazepine derivatives as cholinesterase inhibitors |
US5705515A (en) * | 1994-04-26 | 1998-01-06 | Merck & Co., Inc. | Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity |
US5541197A (en) * | 1994-04-26 | 1996-07-30 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
US5561142A (en) * | 1994-04-26 | 1996-10-01 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
US5656661A (en) * | 1994-07-27 | 1997-08-12 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
US5684002A (en) * | 1994-09-07 | 1997-11-04 | The Procter & Gamble Company | Dihydorbenzofuran and related compounds useful as anti-inflammatory agents |
US6037362A (en) * | 1996-01-10 | 2000-03-14 | Asahi Kasei Kogyo Kabushiki Kaisha | Tricyclic compounds and drug compositions containing the same |
US5672620A (en) * | 1996-02-01 | 1997-09-30 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
US5684031A (en) * | 1996-02-01 | 1997-11-04 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
AU6218598A (en) * | 1997-01-30 | 1998-08-25 | Synthelabo | Alpha-azacyclomethyl benzothiophene and alpha-azacyclomethyl benzofurane derivatives, preparation and therapeutic application |
FR2758820B1 (fr) * | 1997-01-30 | 1999-02-26 | Synthelabo | Derives de alpha-azacyclomethyl-benzofurane, leur preparation et leur application en therapeutique |
DE997458T1 (de) * | 1997-07-03 | 2001-03-01 | Asahi Kasei Kogyo K.K., Osaka | Tricyclische verbindungen mit gesättigten ringen und diese enthaltende medizinische zubereitungen |
AU5257401A (en) | 2000-04-28 | 2001-11-12 | Asahi Chemical Ind | Novel bicyclic compounds |
US7271190B2 (en) | 2001-10-25 | 2007-09-18 | Asahi Kasei Pharma Corporation | Indazole compounds as β3 adrenoceptor agonist |
AU2009301798B2 (en) | 2008-10-09 | 2012-03-01 | Asahi Kasei Pharma Corporation | Indazole compound |
AU2009301797B2 (en) | 2008-10-09 | 2012-03-01 | Asahi Kasei Pharma Corporation | Indazole derivative |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1013224A (en) * | 1962-06-21 | 1965-12-15 | Ici Ltd | Heterocyclic aminoethanols |
US3255249A (en) * | 1963-04-26 | 1966-06-07 | Ici Ltd | 2-branched lower alkyl-amino-1-(indan-, hydrogenated indan- and hydrogenated naphth-2-yl) lower alkanols |
CH442302A (de) * | 1964-04-17 | 1967-08-31 | Sandoz Ag | Verfahren zur Herstellung eines neuen Indolderivates |
FR2138488A1 (en) * | 1971-05-27 | 1973-01-05 | Lipha | 1-(5-indanyl)-omega-aminoalkanes - with tranquillizing activity |
-
1975
- 1975-11-18 FR FR7535217A patent/FR2332010A1/fr active Granted
-
1976
- 1976-11-11 SE SE7612554A patent/SE434744B/sv not_active IP Right Cessation
- 1976-11-12 DE DE2651572A patent/DE2651572C2/de not_active Expired
- 1976-11-15 FI FI763265A patent/FI763265A/fi not_active Application Discontinuation
- 1976-11-17 IL IL50932A patent/IL50932A/xx unknown
- 1976-11-17 AT AT854376A patent/AT355566B/de not_active IP Right Cessation
- 1976-11-17 ES ES453389A patent/ES453389A1/es not_active Expired
- 1976-11-17 MX MX765135U patent/MX4881E/es unknown
- 1976-11-17 NL NLAANVRAGE7612794,A patent/NL180936C/xx not_active IP Right Cessation
- 1976-11-17 DK DK517076A patent/DK151330C/da not_active IP Right Cessation
- 1976-11-17 PT PT65853A patent/PT65853B/pt unknown
- 1976-11-18 CH CH1454276A patent/CH623321A5/fr not_active IP Right Cessation
- 1976-11-18 AU AU19779/76A patent/AU510315B2/en not_active Expired
- 1976-11-18 BE BE172486A patent/BE848496A/xx not_active IP Right Cessation
- 1976-11-18 ZA ZA766907A patent/ZA766907B/xx unknown
- 1976-11-18 IE IE2541/76A patent/IE44265B1/en unknown
- 1976-11-18 NZ NZ182665A patent/NZ182665A/xx unknown
- 1976-11-18 GB GB48127/76A patent/GB1565080A/en not_active Expired
- 1976-11-18 GR GR52209A patent/GR62012B/el unknown
- 1976-11-18 JP JP13785976A patent/JPS5297952A/ja active Granted
- 1976-11-18 CA CA266,041A patent/CA1094088A/en not_active Expired
-
1980
- 1980-03-03 CH CH167280A patent/CH622770A5/fr not_active IP Right Cessation
-
1982
- 1982-01-12 JP JP57002388A patent/JPS6017778B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS6017778B2 (ja) | 1985-05-07 |
NL7612794A (nl) | 1977-05-23 |
AU1977976A (en) | 1978-05-25 |
FR2332010A1 (fr) | 1977-06-17 |
GB1565080A (en) | 1980-04-16 |
DE2651572C2 (de) | 1982-05-19 |
MX4881E (es) | 1982-11-30 |
DK151330B (da) | 1987-11-23 |
CH623321A5 (en) | 1981-05-29 |
JPS57145843A (en) | 1982-09-09 |
CA1094088A (en) | 1981-01-20 |
PT65853B (fr) | 1978-05-15 |
AU510315B2 (en) | 1980-06-19 |
IL50932A0 (en) | 1977-01-31 |
NL180936B (nl) | 1986-12-16 |
CH622770A5 (en) | 1981-04-30 |
JPS5297952A (en) | 1977-08-17 |
FI763265A (sv) | 1977-05-19 |
NL180936C (nl) | 1987-05-18 |
DE2651572A1 (de) | 1977-06-08 |
AT355566B (de) | 1980-03-10 |
FR2332010B1 (sv) | 1979-06-29 |
IL50932A (en) | 1984-01-31 |
GR62012B (en) | 1979-02-15 |
IE44265B1 (en) | 1981-09-23 |
SE7612554L (sv) | 1977-05-19 |
BE848496A (fr) | 1977-05-18 |
ZA766907B (en) | 1977-10-26 |
ATA854376A (de) | 1979-08-15 |
JPS63435B2 (sv) | 1988-01-07 |
ES453389A1 (es) | 1977-11-16 |
IE44265L (en) | 1977-05-18 |
DK517076A (da) | 1977-05-19 |
PT65853A (fr) | 1976-12-01 |
NZ182665A (en) | 1978-11-13 |
SE434744B (sv) | 1984-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK145339C (da) | Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf | |
DK149449C (da) | Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf | |
DK154939C (da) | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf | |
DK152495C (da) | Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf | |
DK163244C (da) | Analogifremgangsmaade til fremstilling af 7-oe2-(2-aminothiazol-4-yl)-2-oxyimino-acetamidoaa-ceph-3-em-4-carboxylsyrederivater eller fysiologisk acceptable salte deraf | |
DK151330C (da) | Analogifremgangsmaade til fremstilling af aminoalkoholderivater eller farmaceutiske acceptable salte deraf | |
DK160250C (da) | Analogifremgangsmaade til fremstilling af 4-substituerede piperidinoalkanon-derivater eller farmaceutisk acceptable salte deraf | |
DK151010C (da) | Analogifremgangsmaade til fremstilling af n-(substitueret aminoalkyl)-2-oxo-1-pyrrolidinacetamider eller farmaceutisk acceptable syreadditionssalte deraf | |
DK154654C (da) | Analogifremgangsmaade til fremstilling af immunmodulerende 2-oe2-acylamino-2-desoxy-(d)-glucosyl-3-oaa-alkancarboxylsyrepeptid-derivater eller farmaceutisk acceptable salte deraf | |
DK152114C (da) | Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf | |
DK149893C (da) | Analogifremgangsmaade til fremstilling af thiazolderivater eller farmaceutisk acceptable salte deraf | |
DK149609C (da) | Analogifremgangsmaade til fremstilling af hydroxyamino-alkan- eller -alkenphosphonsyrederivater eller estere eller salte deraf | |
DK146538C (da) | Analogifremgangsmaade til fremstilling af 7alfa-methoxycephalosporinderivater eller farmaceutisk acceptable salte deraf | |
DK149569C (da) | Analogifremgangsmaade til fremstilling af isoquinolineddikesyre-forbindelser eller farmaceutisk acceptable salte deraf | |
DK5976A (da) | Fremgangsmade til fremstilling af biphenyloxyderivater eller salte heraf | |
DK155670C (da) | Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf | |
DK149230C (da) | Analogifremgangsmaade til fremstilling af 5-benzoyl-6-hydroxy-indan-1-carboxylsyrederivater eller farmaceutisk acceptable salte deraf | |
DK158658C (da) | Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf | |
DK149269C (da) | Analogifremgangsmaade til fremstilling af beta-mono- eller -difluormethyl-beta-alanin-derivater eller farmaceutisk acceptable salte eller optiske isomere deraf | |
DK150196C (da) | Analogifremgangsmaade til fremstilling af 0-(3-amino-2-hydroxypropyl)-amidoximderivater eller farmaceutisk acceptable salte deraf | |
DK145263C (da) | Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf | |
DK149077C (da) | Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
DK143105C (da) | Analogifremgangsmaade til fremstilling af aminobenzocycloheptenderivater eller farmaceutisk acceptable additionssalte deraf | |
DK152208C (da) | Analogifremgangsmaade til fremstilling af 2-phenylamino-phenyleddikesyreamider eller farmaceutisk acceptable salte deraf | |
DK149093C (da) | Analogifremgangsmaade til fremstilling af pentapeptidderivater eller farmaceutisk acceptable salte deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |